-The Times of India Vina Mazumdar, academic, activist and one of the pioneers of women's studies in India, passed away on May 30. Renowned anthropologist Joan Mencher pays her a tribute. Vina Mazumdar (1927-2013)-"Vinadi" to colleagues and friends-a veteran fighter for Indian women's rights and pioneer of feminist studies, passed away in Delhi on May 30, 2013. She had been ailing since March of this year. I first met her in the...

-Economic and Political Weekly   A report on the 2013 deliberation of the Kolkata Group at its 10th workshop which focused on healthcare, the status of women and social justice in India. A K Shiva Kumar (akshivakumar@gmail.com) is convener of the Kolkata Group workshops which are organised by Pratichi (India) Trust, the Harvard Global Equity Initiative and UNICEF India. At the 10th annual Kolkata Group workshop in February this year, 40 policymakers, development practitioners,...

-The Times of India MUMBAI: It's widely known that a month's dose of cancer drugs can cost lakhs, but what isn't common knowledge is that Tata Memorial Hospital's doctors are working on alternatives that could cost less than Rs 1,000 a month. Dubbed the metronomic treatment protocol, it comprises daily consumption of a combination of low-dose medicines that are cheap because they have been around for decades. "There is no need to...

-Tehelka.com There are few figures from the adivasi community in India who have made a bigger dent in the collective imagination of the country than Dayamani Barla. The "iron lady of Jharkhand" has been instrumental in articulating adivasi struggles against displacement and deprivation on national and international platforms. Dayamani, who was recently imprisoned in Jharkhand for her involvement in the Nagri people's movement, has won the first Ellen L Lutz Indigenous...

-The Business Standard Angelina Jolie has inadvertently highlighted a key question about patenting Angelina Jolies recent double mastectomy was obviously a very radical decision. It is unusual for a healthy person to opt for pre-emptive surgery to avert the probability, however high it may be, of getting cancer. The tests Jolie relied on are also at the heart of a legal battle, which could affect US biotech patenting norms. Since the US...